Molecular status of individual CFU-GM colonies derived from chemotherapy-mobilised peripheral blood stem cells in chronic myeloid leukaemia

Genes Chromosomes and Cancer

Volumn 18, Issue 4, 1997, Pages 292-298

  Broughton, Caroline M ^a   Sherrington, Paul ^a   Pender, Norman T ^a   Clark, Richard E ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CYTARABINE; DAUNORUBICIN; IDARUBICIN; MESSENGER RNA; TIOGUANINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COLONY FORMING UNIT GM; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; ONCOGENE; ORAL DRUG ADMINISTRATION; PERIPHERAL BLOOD STEM CELL; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FUSION PROTEINS, BCR-ABL; GRANULOCYTES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-NEGATIVE; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MACROPHAGES; PHILADELPHIA CHROMOSOME; RNA, MESSENGER; STEM CELLS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0030935898     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199704)18:4<292::AID-GCC7>3.0.CO;2-W     Document Type: Article

References (27)

1. Allan NC, Richards SM, Shepherd PCA, on behalf of the UK Medical Research Councils Working Parties for Therapeutic Trials in Adult Leukaemia (1995) UK Medical Research Council randomised multicentre trial of interferon-αn1 for chronic myeloid leukaemia: Improved survival irrespective of cytogenetic response. Lancet 345:1392-1397.
2. Bedi A, Zehnbauer BA, Collector MI, Barber JP, Zicha MS, Sharkis SJ, Jones RJ (1994) BCR-ABL gene re-arrangement and expression of primitive haematopoietic progenitors in chronic myeloid leukaemia. Blood 81:2898-2902.
3. Carella AM, Gaozza E, Raffo MR, Carlier P, Frassoni F, Valbonesi M, Lercari G, Sessarego M, Defferrari R, Guerrasio A, Saglio G, Canepa L, Gaetani GF, Occhini D (1991) Therapy of acute phase chronic myclogenous leukaemia with intensive chemotherapy, blood cell autotransplant and cyclosporine A. Leukemia 5:517-521.
4. Carella AM, Podesta M, Frassoni F, Raffo MR, Pollicardo N, Pungolino E, Vimercati R, Sessarego M, Parodi C, Rabitti C, Ferrero R, Benvenuto F, Figari O, Carlier P, Levcasic G, Valbonesi M, Vitale V, Giordano D, Pierluigi D, Nati S, Guerraçio A, Rosso C, Saglio G (1993) Collection of "normal" blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia. Bone Marrow Transplant 12:267-271.
5. Carlo-Stella C, Mangoni L, Piovani G, Garau D, Almici C, Rizzoli V (1994) Identification of Philadelphia-negative granulocyte-macrophage colony-forming units generated by stroma-adherent cells from chronic myelogenous leukaemia patients. Blood 83:1373-1380.
6. Chalmers EA, Franklin IM, Kelsey S, Clark RE, Sproul AM, Goldstone AH, Hepplestone A, Watson W, Sharp S, Tansey P (1994) Mobilisation of Ph-negative peripheral blood stem cells in CML with Idarubicin and Cytarabine. Bone Marrow Transplant 14 (Suppl 3):38-41.
7. Chalmers EA, Franklin IM, Kelsey SM, Newland AC, Clark RE, Sproul AM, Crotty G, McCann SR, Fielding A, Goldstone AH, Hepplestone A, Watson W, Sharp RA, Tansey P (1995) Philadelphia negative PBSC mobilisation in chronic phase CML following idarubicin and cytarabine therapy [abstract]. Br J Haematol 89 (Suppl 1):15.
8. de Fabritiis P, Amadori S, Petti MC, Mancini M, Montefusco E, Picardi A, Geiser T, Campbell K, Calabretta B, Mandelli F (1995) In vitro purging with BCR-ABL antisense oligodeoxynucleotides does not prevent haematological reconstitution after autologous bone marrow transplantation. Leukemia 9:662-664.
9. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contibute to relapse after autologous bone marrow in CML. Blood 83:3068-3076.
10. Diamond J, Goldman JM, Melo JV (1995) BCR-ABL, ABL-BCR, BCR and ABL genes are all expressed in individual granulocyte-macrophage colonies derived from blood of patients with chronic myeloid leukaemia. Blood 85:2171-2175.
11. Don RH, Cox PT, Wainwright BJ, Baker K, Mattick JS (1991) "Touchdown" PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 19:4008.
12. Dubé ID, Eaves CJ, Kalousek DK, Eaves AC (1981) A method for obtaining high quality chromosome preparations from single hematopoietic colonies on a routine basis. Cancer Genet Cytogenet 4:157.
13. Eaves CJ (1992) Biology of chronic myeloid leukaemia. Br J Haematol 82:199-200.
14. Fainstein E, Einat M, Gokkel E, Marcelle C, Croce CM, Gale RP, Canaani E (1989) Nucleotide sequence analysis of human ABL and BCR-ABL cDNAs. Oncogene 4:1477-1481.
15. Giles RV, Spiller DG, Green JA, Clark RE, Tidd DM (1995) Optimisation of antisense oligodeoxynucleotide structure for targeting BCR-ABL mRNA. Blood 86:744-754.
16. Hoyle C, Gray R, Goldman J (1994) Autografting for patients with CML in chronic phase: An update. Br J Haematol 86:76-81.
17. Italian Co-operative Study Group on Chronic Myeloid Leukaemia (1994) Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukaemia. N Engl J Med 330:820-825.
18. + cell population from peripheral blood of CML patients contains BCR-ABL-negative progenitor cells. Exp Hematol 23:1509-1514.
19. + cells arising from hematopoietic progenitors in chronic myeloid leukaemia. Blood 83:1744-1749.
20. LeFranc M-P, Forster A, Baer R, Stinson MA, Rabbitts TH (1986) Diversity and re-arrangement of the human T-cell rearranging τ genes: Nine germ line variable genes belonging to two subgroups. Cell 45:237-246.
21. Lifshitz B, Fainstein E, Marcelle C, Shtivelman E, Amson R, Gale RP, Canaani E (1987) BCR genes and transcripts. Oncogene 2:113-117.
22. McGlave PB, De Fabritiis P, Deisseroth A, Goldman J, Barnett M, Reiffers J, Simonsson B, Carella A, Aeppli D (1994) Autologous transplants for chronic myelogenous leukaemia: Results from eight transplant groups. Lancet 343:1486-1488.
23. Ponte P, Ng SY, Engel J, Gunning P, Kedes L (1984) Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res 12:1687-1696.
24. Testa NG, Dexter TM (1991) The biology of long-term marrow cultures and its application to bone marrow transplantation. Curr Opin Oncol 3:272-278.
25. Turhan AG, Humphries RK, Eaves CJ, Barnet MJ, Phillips GL, Kalousek DK, Klingemann HG, Lansdorp PL, Reece DE, Shepherd JD, Eaves AC (1990) Detection of breakpoint cluster region-negative and nonclonal hematopoiesis in vitro and in vivo after transplantation of cells selected in cultures of chronic myeloid leukaemia marrow. Blood 76:2404-2410.
26. Tutschka PJ, Copelan EA, Klein JP (1987) Bone marrow transplantation for leukaemia following a new busulfan and cyclophosphamide regimen. Blood 70:1382-1388.
27. Verfaillie CM, Miller WJ, Boylan K, McGlave PB (1992) Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukaemia on the basis of HLA-DR antigen expression. Blood 79:1003-1010.